Clinical Trial Update: ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) [Phase 2]

View source ↗

Summary

Phase 2 trial update for adalimumab in persistent early oligoarthritis (ADEOS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligoarthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University of Leeds | Conditions: Oligoarthritis | Phase 2 | Status: COMPLETED